ATE290013T1 - Neutralsierungs-assay, das humane papillomavirus- ähnliche partikel verwendet - Google Patents
Neutralsierungs-assay, das humane papillomavirus- ähnliche partikel verwendetInfo
- Publication number
- ATE290013T1 ATE290013T1 AT99967436T AT99967436T ATE290013T1 AT E290013 T1 ATE290013 T1 AT E290013T1 AT 99967436 T AT99967436 T AT 99967436T AT 99967436 T AT99967436 T AT 99967436T AT E290013 T1 ATE290013 T1 AT E290013T1
- Authority
- AT
- Austria
- Prior art keywords
- particles
- human papillomavirus
- neutralization assay
- pseudovirions
- vlp
- Prior art date
Links
- 238000003556 assay Methods 0.000 title abstract 2
- 239000002245 particle Substances 0.000 title abstract 2
- 238000006386 neutralization reaction Methods 0.000 title 1
- 108700008625 Reporter Genes Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 208000003154 papilloma Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11338898P | 1998-12-23 | 1998-12-23 | |
| PCT/US1999/030297 WO2000039151A1 (en) | 1998-12-23 | 1999-12-20 | Neutralizing assay using human papillomavirus virus-like particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE290013T1 true ATE290013T1 (de) | 2005-03-15 |
Family
ID=22349108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99967436T ATE290013T1 (de) | 1998-12-23 | 1999-12-20 | Neutralsierungs-assay, das humane papillomavirus- ähnliche partikel verwendet |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1140974B1 (de) |
| JP (1) | JP2002535965A (de) |
| AT (1) | ATE290013T1 (de) |
| AU (1) | AU763853B2 (de) |
| CA (1) | CA2355883A1 (de) |
| DE (1) | DE69924007T2 (de) |
| ES (1) | ES2237204T3 (de) |
| WO (1) | WO2000039151A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2415763A1 (en) * | 2000-07-07 | 2002-01-17 | Merck & Co., Inc. | Production of chimeric human papillomavirus |
| JP2004532012A (ja) * | 2001-03-02 | 2004-10-21 | メルク エンド カムパニー インコーポレーテッド | ウイルスリポーター粒子 |
| AU2003296902A1 (en) * | 2002-09-03 | 2004-05-04 | Kentucky Bioprocessing, Llc | Production of peptides in plants as viral coat protein fusions |
| MY140664A (en) * | 2003-09-29 | 2010-01-15 | Merck Sharp & Dohme | Optimized expression of hpv 45 l1 in yeast |
| US20130149696A1 (en) * | 2010-06-02 | 2013-06-13 | European Molecular Biology Laboratory | High-throughput method for determining the presence of papillomavirus-neutralizing antibodies in a sample |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM566794A0 (en) * | 1994-05-17 | 1994-06-09 | University Of Queensland, The | Process and product |
| US5795754A (en) * | 1995-07-19 | 1998-08-18 | Merck & Co., Inc. | Synthetic HPV11 virus-like particles |
| WO1998025646A1 (en) * | 1996-12-09 | 1998-06-18 | Merck & Co., Inc. | Synthetic hpv16 virus-like particles |
-
1999
- 1999-12-20 AT AT99967436T patent/ATE290013T1/de not_active IP Right Cessation
- 1999-12-20 EP EP99967436A patent/EP1140974B1/de not_active Expired - Lifetime
- 1999-12-20 CA CA002355883A patent/CA2355883A1/en not_active Abandoned
- 1999-12-20 ES ES99967436T patent/ES2237204T3/es not_active Expired - Lifetime
- 1999-12-20 WO PCT/US1999/030297 patent/WO2000039151A1/en not_active Ceased
- 1999-12-20 AU AU23710/00A patent/AU763853B2/en not_active Ceased
- 1999-12-20 JP JP2000591062A patent/JP2002535965A/ja not_active Withdrawn
- 1999-12-20 DE DE69924007T patent/DE69924007T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69924007T2 (de) | 2006-04-06 |
| JP2002535965A (ja) | 2002-10-29 |
| DE69924007D1 (de) | 2005-04-07 |
| EP1140974A4 (de) | 2003-06-11 |
| AU763853B2 (en) | 2003-07-31 |
| AU2371000A (en) | 2000-07-31 |
| EP1140974B1 (de) | 2005-03-02 |
| WO2000039151A1 (en) | 2000-07-06 |
| ES2237204T3 (es) | 2005-07-16 |
| CA2355883A1 (en) | 2000-07-06 |
| EP1140974A1 (de) | 2001-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Becker et al. | MC polyomavirus is frequently present in Merkel cell carcinoma of European patients | |
| Frazer | Development and implementation of papillomavirus prophylactic vaccines | |
| JP2014012738A (ja) | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 | |
| FR11C0022I2 (fr) | Production de proteine de capside de virus du papillome humain et particules de type viral | |
| CY1108106T1 (el) | Χειμερικα μορια l1 ανθρωπινου θηλωματοϊου (hpv) και χρησεις τους | |
| IL154566A0 (en) | Diagnosis method of fibrotic disease using biochemical markers | |
| Pfister | Papillomaviruses: general description, taxonomy, and classification | |
| WO2006075245A3 (en) | Systems, methods, and compositions for detection of human papilloma virus in biological samples | |
| EP2361930A3 (de) | Multimere von peptide-mhc komplexen und deren verwendung in borrelia infektionskrankheiten | |
| ATE417897T1 (de) | Sulfonierte 8,9 benzophenoxazinfarbstoffe und die verwendung ihrer markierten konjugate | |
| ATE290013T1 (de) | Neutralsierungs-assay, das humane papillomavirus- ähnliche partikel verwendet | |
| CN108918872A (zh) | 一种检测凝血酶的纸基光致电化学免疫传感器的构建方法 | |
| EP1230932A3 (de) | Verwendung von Antikörpern zur Vakzinierung gegen Krebs | |
| DK1523497T3 (da) | HSP 70 fra Arthrobacter | |
| WO2001056456A3 (en) | Methods and compositions for detection of disease | |
| EP1309342A4 (de) | Herstellung eines chimeren papillomavirus(22.01.2) | |
| CN103645316A (zh) | 一种基于链霉亲和素功能化半导体纳米材料的肿瘤标志物电化学免疫传感器及其制备方法 | |
| Fecek et al. | Production of Alexa Fluor 488-labeled reovirus and characterization of target cell binding, competence, and immunogenicity of labeled virions | |
| EP0863982A4 (de) | Synthetische hpv11 virusartige partikel | |
| DK0750669T3 (da) | Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra | |
| ATE189897T1 (de) | Antikörper gegen das prorenin profragment, reninaktive substanz die diese enthält und prorenintest die diese verwendet | |
| Jacobelli et al. | Anti-HPV16 E2 protein T-cell responses and viral control in women with usual vulvar intraepithelial neoplasia and their healthy partners | |
| CN104132984B (zh) | 单壁碳纳米角‑铂钯纳米粒和巨细胞病毒pp65抗体修饰电极及其制备方法和应用 | |
| Sapp et al. | Synthesis, properties and applications of papillomavirus-like particles | |
| Buyck | Two remarkable new African Russula species with reddening context |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |